Real-life impact of clinical metagenomics in the intensive care unit: a multicenter retrospective study in greater paris area hospitals
Rattachement africain : fr. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: Infection are the leading cause of intensive care unit (ICU) admission, yet conventional microbiological methods frequently fail to identify the causative pathogen. Metagenomic next-generation sequencing (mNGS) is an emerging, unbiased, pan-pathogen diagnostic tool. However, its real-world microbiological and clinical impact in the ICU remains poorly characterized. This study aimed to assess the microbiological yield and clinical impact of mNGS when implemented in routine ICU practice. METHODS: This retrospective multicenter study was conducted across ten tertiary-care ICUs in the Greater Paris area between January 2018 and April 2024. All patients for whom an mNGS analysis was requested by clinicians from a microbiological sample were included. Any additional pathogens identified by mNGS were independently classified as causative, possibly causative, or non-causative by two reviewers. The independent reviewers also categorised therapeutic changes attributable to mNGS as escalation, de-escalation, discontinuation, or other decision support. Discrepancies were adjudicated by a third reviewer. RESULTS: A total of 144 mNGS analyses were performed in 132 critically ill patients (median age 55 years), 31% of whom were immunocompromised. The number of mNGS analyses requested increased each year. The most common sample types were cerebrospinal fluid (CSF) (n = 60/144, 41.7%) and pleural fluid (n = 21/144, 14.6%). Pathogens were identified by mNGS in 58 samples (40.3%), with a higher yield in pleural fluid (n = 11/21, 52.4%) than in CSF (n = 16/60, 26.6%). Of the 107 pathogens identified, 43 (40.2%) were detected exclusively by mNGS, notably anaerobic bacteria in pleural fluid and abscess samples. mNGS identified an additional pathogen in 34 cases (25.8%) of the 132 patients included, which was deemed causative in 18 cases (13.6%). mNGS findings influenced therapeutic management in seven patients (5.3%) including five cases of antibiotic de-escalation, one appropriate antibiotic escalation, and one case of clinical decision support. CONCLUSION: In this real-life ICU cohort, mNGS identified additional pathogens in 25.8% of patients, deemed causative in 18 cases (13.6%), and a direct therapeutic impact was observed in 5.3% of cases. However, the median turnaround time of 14 days likely limited its clinical impact. Further studies are needed to better define the role of mNGS in the diagnostic management of critically ill patients.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Real-life impact of clinical metagenomics in the intensive care unit: a multicenter retrospective study in greater paris area hospitals
- Date Crossref
- 08/01/2026
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Inserm pays non établi dans la noticeOrganisme public
-
Université Paris-Est Créteil Department of Microbiology pays non établi dans la noticeUniversité ou école supérieure
-
Assistance Publique – Hôpitaux de Paris pays non établi dans la noticeÉtablissement de santé
-
Hôpitaux Universitaires Henri-Mondor pays non établi dans la noticeÉtablissement de santé
-
Institut Mondor de Recherche Biomédicale pays non établi dans la noticeStructure de recherche
-
École Nationale Vétérinaire d'Alfort pays non établi dans la noticeUniversité ou école supérieure
-
Université de Versailles Saint-Quentin-en-Yvelines pays non établi dans la noticeUniversité ou école supérieure
-
Centre de recherche en Epidémiologie et Santé des Populations pays non établi dans la noticeStructure de recherche
-
Sorbonne Université Hôpital Tenon pays non établi dans la noticeUniversité ou école supérieure
-
Hôpital Tenon pays non établi dans la noticeÉtablissement de santé
-
SoLID : SOrbonne study group for Lung Infectious Diseases pays non établi dans la noticeStructure de recherche
-
Lyon 1 Université pays non établi dans la noticeUniversité ou école supérieure
Inserm, Department of Microbiology — Université Paris-Est Créteil et Assistance Publique – Hôpitaux de Paris, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.